1McGowan TA,Dunn SR,Falkner B,et al.Stimulation of Urinary TGF-{beta} and Isoprostanes in Response to Hyperglycemia in Humans[J].Clin J Am Soc Nephrol,2006,1(2):263-268.
2Koya D,Haneda M,Nakagawa H,et al.Amelioration of accelerated diabetic mesangial expansion by treatment with a PKC beta inhibitor in diabetic db/db mice,a rodent model for type 2 diabetes[J].J Faseb,2000,14(3):439-47.
3Weigert C,Brodbeck K,Klopfer K,et al.Angiotensin Ⅱ induces human TGF-beta 1 promoter activation:similarity to hyperglycaemia[J].Diabetogia,2002,45(6):890-898.
4Nath KA,Grande J,Croatt A,et al.Redox regulation of renal DNA synthesis,transforming growth factor-[bgr]1 and collagen gene expression[J].Clin chem,1998,53(2):367.
5Melhem MC,Liachenko J,Derubertis FR.Alpha-lipoic acid attenuates hyperglycemia and prevents glomerular mesangial matrix expansion in diabetes[J].J Am Soc Nephrol,2002,13:108-116.
6Derubertis F,Craven P,Melhem M,et al.Attenuation of renal injury in db/db mice overexpressing superoxide dismutase:evidence for reduced superoxide-nitric oxide interaction[J].Diabetes,2004,53:762-768.
7Cosenzi A,Bernobich E,Tervisan R,et al.Nephroprotective effect of bosentan in diabetic rates[J].J Cardiovasc Pharmacol,2003,42:752-756.
8Cavaletti G,Miloso M,Nicolini G,et al.Emerging role of mitogenactivated protein kinase in peripheral neuropathies[J].J Peripher Nerv Syst,2007,12(3):175-194.
